FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - Measure, Authority Who

144 resources

Type: Text:

By Version

By Realm

  • none: 131
  • uv: 13

 

PackageVersionIdentityName/TitleStatusFMMWGDateRealm
smart.who.int.hivR4Measure/HIVIND35HIV.IND.35 ARV toxicity prevalencedraft2024-08
smart.who.int.hivR4Measure/HIVIND41HIV.IND.41 ART coverage in breastfeeding mothersdraft2024-08
smart.who.int.hivR4Measure/HIVIND39HIV.IND.39 Infant ARV prophylaxis coveragedraft2024-08
smart.who.int.hivR4Measure/HIVIND38HIV.IND.38 Early infant diagnosis (EID) coveragedraft2024-08
smart.who.int.hivR4Measure/HIVIND42HIV.IND.42 Final outcome of PMTCTdraft2024-08
smart.who.int.hivR4Measure/HIVIND37HIV.IND.37 Viral suppression at labour and deliverydraft2024-08
smart.who.int.hivR4Measure/HIVIND40HIV.IND.40 ART coverage in pregnant womendraft2024-08
smart.who.int.hivR4Measure/HIVIND14HIV.IND.14 OAMT minimum dosedraft2024-08
smart.who.int.hivR4Measure/HIVIND13HIV.IND.13 OAMT minimum durationdraft2024-08
smart.who.int.hivR4Measure/HIVIND6HIV.IND.6 PEP completiondraft2024-08
smart.who.int.hivR4Measure/HIVIND7HIV.IND.7 HIV in PEP recipientsdraft2024-08
smart.who.int.hivR4Measure/HIVIND11HIV.IND.11 OAMT coveragedraft2024-08
smart.who.int.hivR4Measure/HIVIND76HIV.IND.76 Presence of STI syndrome, HIV prevention servicesdraft2024-08
smart.who.int.hivR4Measure/HIVIND78HIV.IND.78 Repeat diagnosis of STI syndrome, HIV prevention servicesdraft2024-08
smart.who.int.hivR4Measure/HIVIND70HIV.IND.70 Gonorrhoea testing coverage, HIV prevention servicesdraft2024-08
smart.who.int.hivR4Measure/HIVIND74HIV.IND.74 Gonorrhoea treatment coverage, HIV prevention servicesdraft2024-08
smart.who.int.hivR4Measure/HIVIND66HIV.IND.66 Syphilis treatment coverage, HIV prevention servicesdraft2024-08
smart.who.int.hivR4Measure/HIVIND83HIV.IND.83 HCV test coverage, HIV prevention servicesdraft2024-08
smart.who.int.hivR4Measure/HIVIND80HIV.IND.80 HBV test coverage, HIV prevention servicesdraft2024-08
smart.who.int.hivR4Measure/HIVIND62HIV.IND.62 Syphilis test positivity, HIV prevention servicesdraft2024-08
smart.who.int.hivR4Measure/HIVIND58HIV.IND.58 Syphilis testing coverage, HIV prevention servicesdraft2024-08
smart.who.int.hivR4Measure/HIVIND88HIV.IND.88 HCV positivity, HIV prevention servicesdraft2024-08
smart.who.int.hivR4Measure/HIVIND53HIV.IND.53 Multi-month ARV dispensingdraft2024-08
smart.who.int.hivR4Measure/HIVIND92HIV.IND.92 HCV cured among people living with HIVdraft2024-08
smart.who.int.hivR4Measure/HIVIND90HIV.IND.90 HBV treatment among people living with HIVdraft2024-08
smart.who.int.hivR4Measure/HIVIND91HIV.IND.91 HCV treatment among people living with HIVdraft2024-08
smart.who.int.hivR4Measure/HIVIND77HIV.IND.77 Presence of STI syndrome, HIV-positive clientsdraft2024-08
smart.who.int.hivR4Measure/HIVIND79HIV.IND.79 Repeat diagnosis of STI syndrome, HIV-positive clientsdraft2024-08
smart.who.int.hivR4Measure/HIVIND57HIV.IND.57 Viral suppression among people living with HIV engaged in DSD ART modelsdraft2024-08
smart.who.int.hivR4Measure/HIVIND55HIV.IND.55 Coverage of DSD ART models among people living with HIV on ARTdraft2024-08
smart.who.int.hivR4Measure/HIVIND52HIV.IND.52 TB treatment initiation among diagnoseddraft2024-08
smart.who.int.hivR4Measure/HIVIND50HIV.IND.50 TB testing among those symptom-screened positivedraft2024-08
smart.who.int.hivR4Measure/HIVIND51HIV.IND.51 TB diagnosis among those tested for TBdraft2024-08
smart.who.int.hivR4Measure/HIVIND47HIV.IND.47 People living with HIV with active TB diseasedraft2024-08
smart.who.int.hivR4Measure/HIVIND48HIV.IND.48 TB screening coverage among new ART patientsdraft2024-08
smart.who.int.hivR4Measure/HIVIND49HIV.IND.49 TB symptom-screened positive among new ART patientsdraft2024-08
smart.who.int.hivR4Measure/HIVIND29HIV.IND.29 People living with HIV on ART who have suppressed viral loaddraft2024-08
smart.who.int.hivR4Measure/HIVIND32HIV.IND.32 Viral load testing coveragedraft2024-08
smart.who.int.hivR4Measure/HIVIND34HIV.IND.34 Appropriate second viral load test after adherence counsellingdraft2024-08
smart.who.int.hivR4Measure/HIVIND71HIV.IND.71 Gonorrhoea testing coverage, HIV-positive clientsdraft2024-08
smart.who.int.hivR4Measure/HIVIND75HIV.IND.75 Gonorrhoea treatment coverage, HIV-positive clientsdraft2024-08
smart.who.int.hivR4Measure/HIVIND67HIV.IND.67 Syphilis treatment coverage, HIV-positive clientsdraft2024-08
smart.who.int.hivR4Measure/HIVIND31HIV.IND.31 Late ART initiationdraft2024-08
smart.who.int.hivR4Measure/HIVIND73HIV.IND.73 Gonorrhoea test positivity, HIV-positive clientsdraft2024-08
smart.who.int.hivR4Measure/HIVIND84HIV.IND.84 HCV test coverage, HIV-positive clientsdraft2024-08
smart.who.int.hivR4Measure/HIVIND81HIV.IND.81 HBV test coverage, HIV-positive clientsdraft2024-08
smart.who.int.hivR4Measure/HIVIND63HIV.IND.63 Syphilis test positivity, HIV-positive clientsdraft2024-08
smart.who.int.hivR4Measure/HIVIND59HIV.IND.59 Syphilis testing coverage, HIV-positive clientsdraft2024-08
smart.who.int.hivR4Measure/HIVIND46HIV.IND.46 TB diagnostic testing typedraft2024-08
smart.who.int.hivR4Measure/HIVIND89HIV.IND.89 HCV positivity, HIV-positive clientsdraft2024-08
smart.who.int.hivR4Measure/HIVIND21HIV.IND.21 Linkage to ARTdraft2024-08
smart.who.int.hivR4Measure/HIVIND54HIV.IND.54 Uptake of DSD ART models among people living with HIVdraft2024-08
smart.who.int.hivR4Measure/HIVIND3HIV.IND.3 PrEP coveragedraft2024-08
smart.who.int.hivR4Measure/HIVIND56HIV.IND.56 Retention in DSD ART modelsdraft2024-08
smart.who.int.hivR4Measure/HIVIND25HIV.IND.25 HIV retesting coveragedraft2024-08
smart.who.int.hivR4Measure/HIVIND9HIV.IND.9 Regular NSP accessdraft2024-08
smart.who.int.hivR4Measure/HIVIND8HIV.IND.8 NSP coveragedraft2024-08
smart.who.int.hivR4Measure/HIVIND72HIV.IND.72 Gonorrhoea test positivity, HIV prevention servicesdraft2024-08
smart.who.int.hivR4Measure/HIVIND12HIV.IND.12 Total person-years on OAMTdraft2024-08
smart.who.int.hivR4Measure/HIVIND68HIV.IND.68 Syphilis treatment coverage, pregnant women, first ANC visitdraft2024-08
smart.who.int.hivR4Measure/HIVIND43HIV.IND.43 HIV prevalence among women attending ANCdraft2024-08
smart.who.int.hivR4Measure/HIVIND64HIV.IND.64 Syphilis test positivity, pregnant women, first visitdraft2024-08
smart.who.int.hivR4Measure/HIVIND65HIV.IND.65 Syphilis test positivity, pregnant women, any visitdraft2024-08
smart.who.int.hivR4Measure/HIVIND69HIV.IND.69 Syphilis treatment coverage, pregnant women, any ANC visitdraft2024-08
smart.who.int.hivR4Measure/HIVIND82HIV.IND.82 HBV test coverage, pregnant womendraft2024-08
smart.who.int.hivR4Measure/HIVIND61HIV.IND.61 Syphilis testing coverage, pregnant women, any ANC visitdraft2024-08
smart.who.int.hivR4Measure/HIVIND60HIV.IND.60 Syphilis testing coverage, pregnant women, first ANC visitdraft2024-08
smart.who.int.hivR4Measure/HIVIND95HIV.IND.95 Invasive cervical cancer treatmentdraft2024-08
smart.who.int.hivR4Measure/HIVIND94HIV.IND.94 Pre-invasive cervical disease treatmentdraft2024-08
smart.who.int.hivR4Measure/HIVIND20HIV.IND.20 Individuals testing positive for HIVdraft2024-08
smart.who.int.hivR4Measure/HIVIND24HIV.IND.24 HTS linkage to preventiondraft2024-08
smart.who.int.hivR4Measure/HIVIND96HIV.IND.96 Cervical cancer survivaldraft2024-08
smart.who.int.immunizationsR4Measure/IMMZIND01IMMZIND01draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND02IMMZIND02draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND03IMMZIND03draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND04IMMZIND04draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND05IMMZIND05draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND06IMMZIND06draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND07IMMZIND07draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND08IMMZIND08draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND09IMMZIND09draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND10IMMZIND10draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND11IMMZIND11draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND12IMMZIND12draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND13IMMZIND13draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND14IMMZIND14draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND15IMMZIND15draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND16IMMZIND16draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND17IMMZIND17draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND18IMMZIND18draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND19IMMZIND19draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND20IMMZIND20draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND21IMMZIND21draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND22IMMZIND22draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND23IMMZIND23draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND24IMMZIND24draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND25IMMZIND25draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND26IMMZIND26draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND27IMMZIND27draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND28IMMZIND28draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND29IMMZIND29draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND30IMMZIND30draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND31IMMZIND31draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND32IMMZIND32draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND33IMMZIND33draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND34IMMZIND34draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND35IMMZIND35draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND36IMMZIND36draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND37IMMZIND37draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND38IMMZIND38draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND39IMMZIND39draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND44IMMZIND44draft2025-06
smart.who.int.immunizationsR4Measure/IMMZIND45IMMZIND45draft2025-06
smart.who.int.hivR4Measure/HIVIND44HIV.IND.44 TPT initiationdraft2024-08
smart.who.int.hivR4Measure/HIVIND28HIV.IND.28 Total attrition from ARTdraft2024-08
smart.who.int.hivR4Measure/HIVIND45HIV.IND.45 TPT completiondraft2024-08
smart.who.int.hivR4Measure/HIVIND33HIV.IND.33 Early viral load testing (at six months)draft2024-08
smart.who.int.hivR4Measure/HIVIND18HIV.IND.18 People living with HIV who know their HIV status (first 95)draft2024-08
smart.who.int.hivR4Measure/HIVIND27HIV.IND.27 People living with HIV on ARTdraft2024-08
smart.who.int.hivR4Measure/HIVIND19HIV.IND.19 HTS test volume and positivitydraft2024-08
smart.who.int.hivR4Measure/HIVIND30HIV.IND.30 New ART patientsdraft2024-08
smart.who.int.hivR4Measure/HIVIND5HIV.IND.5 Number of PEP recipientsdraft2024-08
smart.who.int.hivR4Measure/HIVIND2HIV.IND.2 Total PrEP recipientsdraft2024-08
smart.who.int.hivR4Measure/HIVIND22HIV.IND.22 HTS partner servicesdraft2024-08
smart.who.int.hivR4Measure/HIVIND93HIV.IND.93 Cervical cancer screeningdraft2024-08
smart.who.int.hivR4Measure/HIVIND85HIV.IND.85 HBsAg positivity, HIV prevention servicesdraft2024-08
smart.who.int.hivR4Measure/HIVIND86HIV.IND.86 HBsAg positivity, HIV-positive clientsdraft2024-08
smart.who.int.ancR4Measure/ANCIND12ANC.IND.12 Percentage of pregnant women counselled and tested for HIVdraft2025-06uv
smart.who.int.ancR4Measure/ANCIND03ANC.IND.03 Percentage of pregnant women screened for syphilis during ANCdraft2025-06uv
smart.who.int.ancR4Measure/ANCIND02ANC.IND.02 Percentage of pregnant women who received iron and folic acid (IFA) supplements for 90+ daysdraft2025-06uv
smart.who.int.ancR4Measure/ANCIND13ANC.IND.13 Percentage of pregnant women who received oral pre-exposure prophylaxis (PrEP)draft2025-06uv
smart.who.int.hivR4Measure/HIVIND87HIV.IND.87 HBsAg positivity, pregnant womendraft2024-08
smart.who.int.ancR4Measure/ANCIND05ANC.IND.05 Percentage of pregnant women with a minimum of eight antenatal care contactsdraft2025-06uv
smart.who.int.ancR4Measure/ANCIND10ANC.IND.10 Percentage of pregnant women with an ultrasound scan before 24 weeksdraft2025-06uv
smart.who.int.ancR4Measure/ANCIND04ANC.IND.04 Percentage of pregnant women with at least four ANC contactsdraft2025-06uv
smart.who.int.ancR4Measure/ANCIND07ANC.IND.07 Percentage of pregnant women with at least one blood pressure measure during ANCdraft2025-06uv
smart.who.int.ancR4Measure/ANCIND08ANC.IND.08 Percentage of pregnant women with at least one blood pressure measure in the third trimester during ANCdraft2025-06uv
smart.who.int.ancR4Measure/ANCIND01ANC.IND.01 Percentage of pregnant women with first ANC contact in the first trimesterdraft2025-06uv
smart.who.int.ancR4Measure/ANCIND11ANC.IND.11 Percentage of women who received three doses or more of intermittent preventive therapy for malaria (IPTp) during their last pregnancydraft2025-06uv
smart.who.int.ancR4Measure/ANCIND09ANC.IND.09 Percentage of pregnant women whose baby’s heartbeat was listened to at least once during ANCdraft2025-06uv
smart.who.int.ancR4Measure/ANCIND06ANC.IND.06 Pregnant women who received counselling on danger signs (%) during at least one ANC contactdraft2025-06uv
smart.who.int.hivR4Measure/HIVIND15HIV.IND.15 VMMC scale-updraft2024-08
smart.who.int.hivR4Measure/HIVIND4HIV.IND.4 Volume of PrEP prescribeddraft2024-08
smart.who.int.hivR4Measure/HIVIND16HIV.IND.16 VMMC adverse eventsdraft2024-08